Form 4: Aehr Test Systems Director Receives Restricted Stock Unit Grant
Insider Transaction Report
Aehr Test Systems Director Fariba Danesh was granted 9,253 restricted stock units, aligning her interests with long-term shareholder value.
Summary
- Director Fariba Danesh of Aehr Test Systems acquired 9,253 shares of common stock in the form of restricted stock units (RSUs) on July 2, 2025, at a price of $0 per share.
- The RSUs are subject to a vesting schedule where one-eighth (1/8) of the total shares will vest at the end of each three full calendar months following the grant date, provided Ms. Danesh continues to serve as a member of the Board of Directors.
- Following this transaction, Ms. Danesh's total beneficial ownership in Aehr Test Systems, including unvested restricted stock units, amounts to 25,643 shares.
- A Power of Attorney, dated June 2, 2023, authorizes Gayn Erickson, Chris Siu, Adil Engineer, and Vernon Rogers to execute and file Section 16 forms on behalf of Fariba Danesh.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive as the RSU grant aligns the director's interests with long-term shareholder value, which is a beneficial governance practice. It is a routine compensation event rather than a direct market signal.
Positives
- The grant of restricted stock units aligns the director's financial interests with the long-term performance and shareholder value of Aehr Test Systems.
- Equity compensation is a standard practice that incentivizes directors to contribute to the company's success.
Future Outlook
NA
Industry Context
This transaction is a routine compensation event for a director, common across publicly traded companies in various industries, including the semiconductor test and burn-in equipment sector where Aehr Test Systems operates. It reflects standard corporate governance practices for aligning executive and director incentives with shareholder interests.
Comparison to Industry Standards
- The grant of restricted stock units to directors is a common compensation practice in the technology and semiconductor industries, aligning director incentives with long-term company performance.
- The vesting schedule, with quarterly vesting over a period, is typical for RSU grants, providing ongoing incentive for continued service and performance.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy Implementation | The grant of restricted stock units to Director Fariba Danesh is an implementation of the company's equity compensation policy for its board members, designed to align their interests with long-term shareholder value. | 2025-07-02 | Enhances alignment between director incentives and company performance, promoting long-term strategic focus. |
| Administrative Authorization | A Power of Attorney was granted by Fariba Danesh, authorizing specific individuals to handle her Section 16 filings (Forms 3, 4, and 5) with the SEC. | 2023-06-02 | Streamlines compliance with SEC reporting requirements for insider transactions. |
Related Party Transactions
- The grant of 9,253 restricted stock units to Director Fariba Danesh constitutes a related party transaction, as it is a compensation arrangement between the company and a member of its board.
Stakeholder Impact
- Shareholders: The RSU grant aligns the director's interests with shareholder value, potentially leading to more focused long-term decision-making.
- Employees: No direct impact mentioned for general employees.
Next Steps
- One-eighth of the restricted stock units will vest at the end of each three full calendar months following July 2, 2025, contingent on continued service as a Board member.
Key Dates
| Date | Description |
|---|---|
| 2023-06-02 | Date Power of Attorney was executed by Fariba Danesh. |
| 2025-07-02 | Date of the restricted stock unit award transaction for Fariba Danesh. |
| 2025-07-09 | Date the Form 4 was signed by the attorney-in-fact for Fariba Danesh. |
Keywords
Aehr Test Systems, AEHR, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, SEC Form 4, Equity Grant, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.